| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.07 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.07 |